Early response to adalimumab predicts long-term remission through 5 years of treatment in patients with ankylosing spondylitis

Early response to adalimumab predicts long-term remission through 5 years of treatment in patients with ankylosing spondylitis

Bibliographic Details
Main Authors: Sieper, Joachim, van der Heijde, Désirée, Dougados, Maxime, Brown, L Steve, Lavie, Frederic, Pangan, Aileen L
Format: Online
Language:English
Published: BMJ Group 2011
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3329233/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3329233/

Similar Items